+40-31 437 80 13

Pfizer’s opposition against registration of RUXXIMLA partially successful

by Zsófia Judit Halmágyi


This article first appeared on WTR Daily, part of World Trademark Review, in November 2021. For further information, please go to www.worldtrademarkreview.com

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.